Advertisement

Topics

Eisai, Broad Institute to develop an antimalarial medicine

14:38 EDT 6 Jun 2017 | CentreWatch

Eisai Inc., the U.S. subsidiary of Tokyo, Japan-based Eisai Co., Ltd., has entered into a new joint research agreement with the Broad Institute, a collaborative research institute which includes researchers from the Massachusetts Institute of Technology and Harvard University, to develop a new antimalarial medicine based on anti-malarial drug targets the team identified last year. The Eisai and Broad Joint […]

The post Eisai, Broad Institute to develop an antimalarial medicine appeared first on CenterWatch News Online.

Original Article: Eisai, Broad Institute to develop an antimalarial medicine

NEXT ARTICLE

More From BioPortfolio on "Eisai, Broad Institute to develop an antimalarial medicine"

Quick Search
Advertisement
 

Relevant Topic

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...